Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,205 shares at an average $2.83 ($6,238)
  2. 4 Open-market buy Chairman and CEO bought 315 shares at an average $2.98 ($938)
  3. 4 Open-market buy Chairman and CEO bought 315 shares at an average $3.27 ($1,029)
  4. 4 Open-market buy Chairman and CEO bought 345 shares at an average $3.04 ($1,049)
  5. 4 Open-market buy Chairman and CEO bought 450 shares at an average $2.88 ($1,295)
  6. 4 Open-market buy Director bought 315 shares at an average $2.98 ($938)
  7. 4 Open-market buy Director bought 315 shares at an average $3.27 ($1,029)
  8. 4 Open-market buy Director bought 345 shares at an average $3.04 ($1,049)
  9. 4 Open-market buy Director bought 450 shares at an average $2.88 ($1,295)
  10. 4 Open-market buy Director bought 2,982 shares at an average $2.98 ($8,881)
  11. 4 Open-market buy Director bought 882 shares at an average $2.98 ($2,627)
  12. 4 Open-market buy Director bought 1,785 shares at an average $2.98 ($5,316)
  13. 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,205 shares at an average $2.98 ($6,567)
  14. 4 Open-market buy Director bought 1,785 shares at an average $3.26 ($5,827)
  15. 4 Open-market buy Director bought 2,414 shares at an average $3.32 ($8,005)
  16. 4 Open-market buy Director bought 714 shares at an average $3.32 ($2,368)
  17. 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,310 shares at an average $3.25 ($7,505)
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. 4 Grant or award Director acquired 2,040 shares (grant or award)

Page 18 of 52 · 1,039 filings